yttrium radioisotopes has been researched along with Age-Related Macular Degeneration in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Douiri, A; Jackson, TL; McHugh, D; Nau, J; Petrarca, R; Richardson, M; Stangos, AN | 1 |
| DeWerd, LA; Holmes, SM; Micka, JA | 1 |
| Avila, MP; Carla, L; Farah, ME; Fuji, G; Nau, J; Rossi, J; Santos, A | 1 |
3 other study(ies) available for yttrium radioisotopes and Age-Related Macular Degeneration
| Article | Year |
|---|---|
Safety testing of epimacular brachytherapy with microperimetry and indocyanine green angiography: 12-month results.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Brachytherapy; Dose-Response Relationship, Radiation; Female; Fluorescein Angiography; Humans; Indocyanine Green; Linear Models; Macular Degeneration; Male; Middle Aged; Prospective Studies; Radiation Injuries; Ranibizumab; Retina; Sensory Thresholds; Strontium Radioisotopes; Tomography, Optical Coherence; Visual Acuity; Visual Field Tests; Visual Fields; Vitrectomy; Yttrium Radioisotopes | 2013 |
Investigation of a 90Sr/90Y source for intra-ocular treatment of wet age-related macular degeneration.
Topics: Brachytherapy; Computer Simulation; Equipment Design; Equipment Failure Analysis; Humans; Macular Degeneration; Models, Biological; Models, Statistical; Organ Specificity; Prostheses and Implants; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Computer-Assisted; Relative Biological Effectiveness; Strontium Radioisotopes; Treatment Outcome; Yttrium Radioisotopes | 2009 |
Three-year safety and visual acuity results of epimacular 90 strontium/90 yttrium brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Brachytherapy; Choroidal Neovascularization; Combined Modality Therapy; Feasibility Studies; Female; Humans; Macular Degeneration; Male; Middle Aged; Prospective Studies; Radiotherapy Dosage; Strontium Radioisotopes; Visual Acuity; Yttrium Radioisotopes | 2012 |